Hooker Furniture (HOFT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Rubrik, Inc. (RBRK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Best Buy Co., Inc. (NYSE:BBY ) Q1 2026 Earnings Conference Call May 29, 2025 8:00 AM ET Company Participants Mollie O'Brien - Head of Investor Relations Corie Barry - Chief Executive Officer Matt Bilunas - Chief Financial Officer Jason Bonfig - Senior Executive Vice President, Customer Offerings and Fulfillment Conference Call Participants Scot Ciccarelli - Truist Securities Michael Baker - DA Davidson Greg Melich - Evercore ISI Loren Eng - Morgan Stanley Peter Keith - Piper Sandler Steven Zaccone - Citi Brian Nagel - Oppenheimer Jonathan Matuszewski - Jefferies Operator Ladies and gentlemen, thank you for standing by. Welcome to …

Victoria's Secret (VSCO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Lululemon (LULU) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NEW YORK, NY / ACCESS Newswire / May 29, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zenas-biopharma-inc-lawsuit-submission-form?prid=150736&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq.

American-manufactured vehicle will launch space station resupply, commercial, and national security American-manufactured vehicle will launch space station resupply, commercial, and national security

Preventative services, social support, health education and more to improve care access, quality and outcomes SACRAMENTO, Calif. , May 29, 2025 /PRNewswire/ -- Health Net, one of California's most experienced Medi-Cal managed care health plans, and the Centene Foundation, the philanthropic arm of Centene Corporation (NYSE: CNC), today announced a partnership investment of more than $7.2 million to expand healthcare services to underserved Californians through mobile health clinics.

New strategic network delivers integrated counsel at the intersection of risk, reputation and growth - backed by sector expertise, genAI solutions and global scale. NEW YORK and ST.

CHICAGO and LONDON , May 29, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, and CF Benchmarks, the leading provider of cryptocurrency benchmark indices, today announced plans to launch four new cryptocurrency reference rates and real-time indices for Arbitrum, Ondo, NEAR and Sui. These reference rates and indices are not tradable futures products.

NEW YORK, NY / ACCESS Newswire / May 29, 2025 / If you suffered a loss on your Compass Group Diversified Holdings, LLC (NYSE:CODI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/compass-diversified-lawsuit-submission-form?prid=150737&wire=1&utm_campaign=20 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 29, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=150738&wire=1&utm_campaign=17 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 29, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=150735&wire=1&utm_campaign=17 or contact Joseph E. Levi, Esq.

SAN DIEGO--(BUSINESS WIRE)-- #Gaming--Jack in the Box Inc. (NASDAQ: JACK) is turning up the volume on late-night cravings with its latest Munchie Meal collab: a flavor-packed, gamer-approved meal designed by none other than T-Pain – music icon, streamer, podcaster, and professional night owl. Introducing The T-Pain Munchie Meal, a curated feast made for marathon sessions – whether you're grinding in Fortnite or vibing to late-night tracks. It's the newest drop in Jack's celebrity Munchie Meal series, fol.

Biotech stocks have underperformed due to sector rotation, rising rates, and regulatory pressures, but I see a contrarian opportunity emerging. A close look at the recent performance of biotech stocks, the innovative pipeline, and AI-driven process improvements suggests the market may be missing the big picture. Institutional investors are getting back in on the action, evident from the strong Q1 in terms of deal activity.

WINCHESTER, Va.--(BUSINESS WIRE)--From high heels and skateboards to cartwheels and fish scales, the latest advertising campaign from Trex [NYSE:TREX], the world's #1 brand of composite decking and residential railing, highlights a new era of outdoor resilience. Aptly titled “Trex Vs,” the series of commercial spots and digital concepts showcases how the brand's Performance-Engineered™ decking and railing enhance and stand up to everyday life. Created by Nashville-based BUNTIN, the “Trex Vs” ca.

Salesforce shares slumped despite topping fiscal first-quarter estimates and raising its full-year outlook due to artificial intelligence tailwinds. Salesforce's results come a day after it announced plans to buy data management company Informatica for $8 billion.

Shell expects to drill in 2028 an exploratory well in Brazil's Pelotas Basin, a new oil exploration frontier in Latin America's No.1 economy, an executive said at an event in Rio de Janeiro on Thursday.

SAN FRANCISCO, May 29, 2025 (GLOBE NEWSWIRE) -- A year ago, Bay Area biotech firm Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) was riding high on the promise of its newly approved cell therapy, Amtagvi. Today, the mood has shifted dramatically.

Perma-Pipe reported strong FY2024 results, with Q4 revenue up 12% YoY and gross margins steady at 33.5%, supported by a record-high backlog of $167.5 million. The company's growth is largely driven by Middle Eastern energy infrastructure expansion, making its outlook highly sensitive to oil prices and government-backed project cycles. Valuation appears reasonable at ~$13/share, with moderate multiples (11.6x P/E, 4.9x EV/EBITDA) and normalized net income nearly doubling YoY after adjusting for one-time tax gains.